Delivery Order SPE2DB20D1100-SPE2DB25FD7H3
- Not listed
- This is a $1,352.09 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of RHOFADE 1% cream with a completion date of July 29, 2024. The contract is not set aside. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies to provide a wide range of medical supplies and prescription drugs to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOFADE 1% CREAM 30GM, with a ceiling value of $1,602.42 and a performance period ending on June 11, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.78 firm fixed-price delivery order is for the supply of RHOFADE 1% Cream, a prescription medication. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, with a value of $2,212.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOFADE 1% cream, a topical medication, and has a completion date of February 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of RHOFADE 1% cream, a pharmaceutical product, with a ceiling value of $1,331.05 and a period of performance ending on October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,317.06 firm fixed-price delivery order is for RHOFADE 1% cream, a 30 gram specialty medication. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of RHOFADE 1% CREAM 30GM to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,488.72 and a completion date of December 10, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
- This federal contract award, valued at $2,533.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of RHOFADE 1% CREAM 30GM, a pharmaceutical product, and has an ultimate completion date of February 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, valued at $2,681.42, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of RHOFADE 1% CREAM 30GM, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- Amerisourcebergen Drug Corp has received a $1,278.19 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562931150 RHOFADE 1% CREAM 30GM. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its Conshohocken, Pennsylvania location in support of DLA medical facilities and treatment programs. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, routinely supports DLA...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7H3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for RHOFADE 1% Cream 30GM under a firm fixed-price contract. The award, issued on July 30, 2025, carries a ceiling value of $2,424.79 and is scheduled for ultimate completion by July 31, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement executed from the company's existing contract vehicle to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through this prime contract. The company's federal procurement portfolio encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, with all reviewed contract awards competitively awarded on an open basis. The work will be performed at the company's Corporate Office location in Conshohocken, PA 19428.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/30/25 |